U.S. Markets open in 7 hrs 50 mins
  • S&P Futures

    3,635.00
    +2.25 (+0.06%)
     
  • Dow Futures

    29,990.00
    -8.00 (-0.03%)
     
  • Nasdaq Futures

    12,111.00
    +35.00 (+0.29%)
     
  • Russell 2000 Futures

    1,852.50
    +1.00 (+0.05%)
     
  • Crude Oil

    45.22
    +0.31 (+0.69%)
     
  • Gold

    1,802.80
    -1.80 (-0.10%)
     
  • Silver

    23.20
    -0.10 (-0.43%)
     
  • EUR/USD

    1.1898
    +0.0001 (+0.0119%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.64
    -1.02 (-4.50%)
     
  • GBP/USD

    1.3343
    -0.0016 (-0.1161%)
     
  • USD/JPY

    104.5000
    +0.0200 (+0.0191%)
     
  • BTC-USD

    18,855.12
    -213.37 (-1.12%)
     
  • CMC Crypto 200

    374.51
    +4.76 (+1.29%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Covetrus: Q3 Earnings Insights

Benzinga Insights
·1 min read

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 52.94% year over year to $0.26, which beat the estimate of $0.18.

Revenue of $1,126,000,000 up by 10.61% from the same period last year, which beat the estimate of $1,050,000,000.

Looking Ahead

Covetrus hasn't issued any earnings guidance for the time being.

Covetrus hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Nov 10, 2020

View more earnings on CVET

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/jmd2epho

Recent Stock Performance

52-week high: $30.13

52-week low: $4.04

Price action over last quarter: Up 15.81%

Company Overview

Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe, and APAC and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.